Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026

EarningsLeqembiPositive

AI Analysis

Summary

BioArctic AB reported that partner Eisai achieved Leqembi sales of 29.3 billion yen in Q2 2026. The disclosure was made alongside Biogen's quarterly report.

Financial Highlights

Revenue

29.3 billion yen (Leqembi Q2 2026)

Outcome Details

Q2 2026 revenue reported

Importance:4/10

Sentiment:

0.50

earningsrevenuecommercialLeqembiQ2 2026

Related Companies

$BIOA-B.ST $ESALY $BIIB

Read the original article

Published by PR Newswire Biotech on July 29, 2026 10:27 AM

Read Original